Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension

Hypertension

Volumn 30, Issue 4, 1997, Pages 953-956

  Takeda, Yoshiyu ^a   Miyamori, Isamu ^a   Yoneda, Takashi ^a   Furukawa, Kenji ^a   Inaba, Satoru ^a   Takeda, Ryoyu ^b   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KKR Hokuriku Hospital   (Japan)

Author keywords

Aldosterone; Mineralocorticoid; Nitric oxide; Nitric oxide synthase; RNA

Indexed keywords

ALDOSTERONE; ALDOSTERONE DERIVATIVE; MESSENGER RNA; MINERALOCORTICOID; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HORMONE ACTION; HYPERTENSION; HYPOTHALAMUS; MEDULLA OBLONGATA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RNA ANALYSIS;

EID: 0030870277     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.953     Document Type: Article

References (36)

1. Moncada S, Palmer R, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Hibbs J Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deaminase and immune nitrogen oxidation to nitrite. Science. 1987;235:473-476.
3. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
4. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
5. Iwai N, Hanai K, Tooyama I, Kitamura Y, Kinoshita M. Regulation of neuronal nitric oxide synthase in rat adrenal medulla. Hypertension. 1995;25:431-436.
6. Takeda Y, Miyamori I. 19-Noraldosterone, a new mineralocorticoid. Endocrine J. 1994;41:483-489.
7. Takeda Y, Lewicka S, Koch S, Vecsei P, Abdelhamid H, Iwuanyanwu T, Harnik M. Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. J Steroid Biochem Mol Biol. 1990;37: 599-604.
8. Takeda Y, Bige K, Iwuanyanwu T, Vecsei P, Harnik M, Abdelhamid H. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism. Steroids. 1991;56:566-570.
9. Takeda Y, Miyamori I, Iki K, Takeda R, Vecsei P. Urinary excretion of 19-noraldosterone, 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism. Acta Endocrinol (Copenh). 1992;126:484-488.
10. Anderson NS, Fanestil DD. Corticoid receptors in rat brain: evidence for an aldosterone receptor. Endocrinology. 1976;98: 676-681.
11. Mellon SH. Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab. 1994;78:1003-1008.
12. Compagnone NA, Bulfone A, Rubenstein JLR, Mellon SH. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology. 1995;136:5212-5223.
13. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology. 1986;118:819-823.
14. Morris DJ, Gorsline J, Tresco PA, Harnik M. The effects of 19-noraldosterone on blood pressure of adrenalectomized spontaneously hypertensive rats. Steroids. 1985;46:1003-1110.
15. Tamada T, Nara Y, Mashimo T, Matsumoto C, Ikeda K, Sawamura M, Yamori Y. Comparison of the genetic background among WKY and SHR (SP) using microsatellite markers. Jpn Heart J. 1996; 37:552.
16. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Takeda R. Gene expression of 11β-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats. Hypertension. 1944; 23:577-580.
17. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press; 1986.
18. Takeda Y, Miyamori I, Wu P, Yoneda T, Furukawa K, Takeda R. Effects of an endothelin receptor antagonist in rats with cyclosporine-indueed hypertension. Hypertension. 1995;26:932-936.
19. Krukoff TL, Gehlen F, Ganten G, Wagner J. Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats. Hypertension. 1995;26:171-176.
20. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714-718.
21. Takeda Y, Miyamori I, Yoneda T, Hatakeyama H, Inaba S, Furukawa K, Mabuchi H, Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J Clin Endocrinol Metab. 1996;81:2797-2800.
22. Bohr DF. What makes the pressure go up? Hypertension. 1981; 14(suppl II):II-160-II-165.
23. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh F-Y, Takeda R. Production of aldosterone in isolated rat blood vessels. Hypertension. 1995;25:170-173.
24. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh F-Y, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology. 1994;135:2283-2286.
25. Gomez-Sanchez CE, Morita H, Zhou M, Cozza EN, Gomez-Sanchez EP. Aldosterone synthase message and activity in the rat brain. In: Proceedings of the 10th International Congress of Endocrinology, International Society of Endocrinology and the Endocrine Society; June 14-15, 1996; San Francisco, Calif. Abstract.
26. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347: 768-770.
27. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 1992;46:755-784.
28. Swanson LW, Sawchenko PE. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci. 1983;6:269-342.
29. Dun NJ, Dun SL, Forstermann U. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience. 1994;59: 429-445.
30. Lu Y, King Y-Q, Qin B-Z, Li J-S. The distribution and origin of axon terminals with NADPH diaphorase activity in the nucleus of the solitary tract of the rat. Neurosci Lett. 1993;171:70-72.
31. Calaresu FR, Yardley CP. Medullary basal sympathetic tone. Annu Rev Physiol. 1988;50:511-524.
32. Takeda Y, Miyamori I, Takeda R. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension. Steroids. 1995;60:137-142.
33. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res. 1992; 70:607-611.
34. ω-nitro-L-arginine) on blood pressure and plasma renin. Clin Exp Hypertens [A]. 1993;15: 819-832.
35. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett. 1991;132:47-50.
36. Harada S, Tokunaga S, Mohohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Cicr Res. 1993;72:511-516.